Choosing between GVHD and delayed engraftment

Nature Medicine

Volumn 15, Issue 4, 2009, Pages 363-364

  Martin, Paul J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1 ANTIGEN; CD1 D; CD40 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 4; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; DISEASE SEVERITY; ENGRAFTMENT; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; NATURAL KILLER T CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY CONTROL; WHOLE BODY RADIATION;

ANIMALS; BONE MARROW TRANSPLANTATION; DISEASE MODELS, ANIMAL; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MICE; NEOPLASMS; RECEPTORS, GRANULOCYTE COLONY-STIMULATING FACTOR; TRANSPLANTATION CONDITIONING; WHOLE-BODY IRRADIATION;

EID: 64149111015     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0409-363     Document Type: Article

References (10)

1. Morris, E.S. et al. Nat. Med. 15, 436-441 (2009).
2. Offner, F. et al. Blood 88, 4058-4062 (1996).
3. Dekker, A. et al. J. Clin. Oncol. 24, 5207-5215 (2006).
4. Ringden, O. et al. J. Clin. Oncol. 22, 416-423 (2004).
5. Ho, V.T. et al. Bone Marrow Transplant. 32, 771-775 (2003).
6. Khoury, H.J. et al. Blood 107, 1712-1716 (2006).
7. Grewal, S.S., Barker, J.J., Davies, S.M. & Wagner, J.E. Blood 101, 4233-4244 (2003).
8. Rocha, V. et al. N. Engl. J. Med. 342, 1846-1854 (2000).
9. Gluckman, E. et al. Exp. Hematol. 32, 397-407 (2004).
10. Hagglund, H. et al. Bone Marrow Transplant. 24, 831-836 (1999).